Compare AstraZeneca plc (AZN) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Unilever plc — how do they compare? AstraZeneca plc trades at $158.19 (market cap $248.14B), while Unilever plc trades at $61.89 (market cap $134.06B). The key difference: AstraZeneca plc is the larger of the two by market cap, and Unilever plc pays the higher dividend (3.65%). Which is the better fit depends on your goals.
| AZN | UL | |
|---|---|---|
Market Cap | $248.14B | $134.06B |
Sector | Health | Consumer Staples |
52-Week High | $209.48 | $74.59 |
52-Week Low | $147.06 | $55.05 |
Enterprise Value | $275.41B | $159.86B |
Dividend Yield | 2.01% | 3.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
